Roopa Prihar

Discussing the value of the subsidiary OmniaBio, as soveriegn capacity that is critical to Canada's needs in the event of future pandemics or national emergency, leading to support from federal entitities that supply capital and other financial products. Continued effort to maintain strong support for strategic value of the Strategic Response Fund support for the project re the application of automation and AI technology in our recently opened cell and gene therapy manufacutring facility operated by the subsidiary OmniaBio. The support will result in lower cost of life saving cell and gene therapy products. Pursue opportunities to benefit the Canadian cell and gene therapy ecosystem caused by global uncertainty.

Engage with federal government officials on possible funding mechanisms under various innovation funds for potential construction of production and other facilities. Discuss with government officials regarding modernization of tax benefits and associated funding programs

Discussions on measures to support the competitiveness of the Canadian aluminum industry in the current trade climate. Propose changes to the Clean Technology Investment Tax Credit to support green transition projects in the manufacturing sector. Promouvoir le développement de nouvelles technologies de production d'aluminium au Canada. Discussion on the design of potential future carbon border adjustment mechanism in Canada. Discussion on CUSMA implementation and impacts of trade barriers (ie 232 tariffs) for market access to the US of Canadian aluminum Démarche avec le Fonds Stratégique pour l’Innovation concernant le projet de technologie avancée de fusion d’aluminium. Demande de financement pour le développement de nouvelles technologies de production d'aluminium au Canada. Sources de financement à déterminer.